Similar Items: A zebrafish larval model for drug-induced hepatic Injury due to first-line antituberculosis drugs and possible prevention/treatment with N-acetyl-cysteine
- The pharmacokinetics and toxicity of antituberculosis agents and other co-administered drugs in children with tuberculosis, with and without HIV infection, and their relationship to nutritional status
- Pharmacokinetics and safety of first -- and second--line anti-- tuberculosis drugs in children
- Sputum derived biomarkers of anti-tuberculosis drug activity in early bactericidal activity (EBA) studies
- An analytical investigation of the impact of crushing of first-line antituberculosis medication and administration via a nasogastric tube
- Overexpression of mmpS5/mmpL5 in Mycobacterium tuberculosis reduces susceptibility to anti-tuberculosis drugs
- Targeting MEP pathway for the development of antitubercular drugs
Author: Kellermann, Tracy
- A Pharmacological investigations of South Africa Lichens, Dessication-tolerant Plants and Medicinal Tree, Warburgia Salutaris
- An analytical investigation of the physiochemical properties of crushed rifapentine administered to paediatrics.
- Development of a platform for rational diagnostic design using a venom-antibody model
- Neurological risk of prolonged low dose exposure to imidacloprid in zebrafish
- Clinical and pre-clinical investigation of sertraline use in pregnancy: bioavailability and risk to offspring
- The development and validation of an LC-MS/MS method for the quantification of ertapenem in human plasma: application to paediatric XDR-TB case studies